妊娠期酒精使用障碍的药物治疗:是时候重新考虑了?
本文综述妊娠期酒精使用障碍(AUD)药物治疗的安全性证据,权衡酒精危害与药物获益。已发表证据很少,仅双硫仑可能致严重胎儿伤害,而阿坎酸和纳曲酮未见重大畸形或其他严重后果的显著风险。基于现有证据,应考虑对妊娠期AUD患者使用阿坎酸和纳曲酮,但仍需更多研究。
要点
- 妊娠期AUD药物治疗罕见,主要因安全性数据缺乏。
- 现有证据中仅双硫仑可能造成严重胎儿伤害。
- 阿坎酸和纳曲酮未显示重大畸形或严重后果的显著风险。
核心结论
- 基于当前证据,应考虑对妊娠期AUD患者使用阿坎酸和纳曲酮治疗,尽管仍需更多研究。
研究设计与样本
- 本文为文献综述,回顾已发表文献并权衡妊娠期饮酒及AUD相关危害与AUD药物(阿坎酸、纳曲酮、双硫仑)的潜在获益。
主要发现
- 支持AUD药物在妊娠期安全性的已发表证据很少。
- 从现有研究来看,可能仅双硫仑有潜在造成严重胎儿伤害的风险。
- 阿坎酸和纳曲酮似乎未与先天畸形或其他严重后果的显著风险相关。
临床怎么用
- 对妊娠期AUD患者,基于现有证据可考虑使用阿坎酸或纳曲酮治疗。
- 双硫仑因潜在严重胎儿伤害风险,应避免用于妊娠期AUD患者。
局限性
- 支持AUD药物在妊娠期安全性的已发表证据很少。
- 仍需进一步研究以确认妊娠期使用阿坎酸和纳曲酮的安全性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
It is generally recommended that medications only be used in pregnancy where the potential harms to both the mother and foetus are outweighed by the potential benefits. Despite the known harms associated with alcohol consumption during pregnancy, the use of medication for the treatment of pregnant women with an alcohol use disorder (AUD) appears to be rare. This is likely due to the lack of available data regarding the safety of these medications in pregnancy. We reviewed the literature and weighed up the harms associated with alcohol use and AUD during pregnancy with the potential benefits of medications for AUD in pregnancy, including acamprosate, naltrexone and disulfiram. There is little published evidence to support the safety of medications for AUD in pregnancy. However, from the research available it is likely that only disulfiram has the potential to cause serious foetal harm. While further research is required, acamprosate and naltrexone do not appear to be associated with substantial risks of congenital malformations or other serious consequences. Given the potential risks associated with alcohol consumption during pregnancy, the use of acamprosate and naltrexone should be considered for the treatment of pregnant women with AUD based on the current evidence base, although more research is warranted.
引用
- Kelty E, Terplan M, Greenland M, et al. Pharmacotherapies for the Treatment of Alcohol Use Disorders During Pregnancy: Time to Reconsider? Drugs. 2021. PMID: 33830479. doi:10.1007/s40265-021-01509-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。